GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

被引:0
|
作者
Cryer, Byron [1 ]
Li, Chunming [2 ]
Simon, Lee S. [3 ]
Singh, Gurkirpal [4 ]
Stillman, Martin J. [5 ]
Berger, Manuela [2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Pfizer Inc, New York, NY USA
[3] SDG LLC, Cambridge, MA USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
[5] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P63
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: A prospective, randomized, open-label, blinded end point (PROBE), parallel-arm study
    Fogari, Roberto
    Zoppi, Annalisa
    Mugellini, Amedeo
    Preti, Paola
    Destro, Maurizio
    Rinaldi, Andrea
    Derosa, Giuseppe
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2008, 69 (01): : 1 - 15
  • [22] An open-label, 6-month study of allopurinol safety in gout: The LASSO study
    Becker, Michael A.
    Fitz-Patrick, David
    Choi, Hyon K.
    Dalbeth, Nicola
    Storgard, Chris
    Cravets, Matt
    Baumgartner, Scott
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (02) : 174 - 183
  • [23] Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study
    Miller, Brian J.
    Claxton, Amy
    Du, Yangchun
    Weiden, Peter J.
    Potkin, Steven G.
    SCHIZOPHRENIA RESEARCH, 2019, 208 : 44 - 48
  • [24] The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
    Angelo Tremblay
    Jean-Philippe Chaput
    Sonia Bérubé-Parent
    Denis Prud’homme
    Claude Leblanc
    Natalie Alméras
    Jean-Pierre Després
    European Journal of Clinical Pharmacology, 2007, 63
  • [25] The effect of topiramate on energy balance in obese men:: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
    Tremblay, Angelo
    Chaput, Jean-Philippe
    Berube-Parent, Sonia
    Prud'homme, Denis
    Leblanc, Claude
    Almeras, Natalie
    Despres, Jean-Pierre
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (02) : 123 - 134
  • [26] Etanercept in the treatment of psoriasis vulgaris: Results from an open-label 6-month study
    Stratigos, A. J.
    Avgerinou, G.
    Dessinioti, C.
    Antoniou, C.
    Stavropoulos, P. G.
    Katsambas, A. D.
    EADV: PROCEEDINGS OF THE 15TH CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, : 721 - +
  • [27] Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point Trial
    Gulsin, Gaurav S.
    Swarbrick, Daniel J.
    Athithan, Lavanya
    Brady, Emer M.
    Henson, Joseph
    Baldry, Emma
    Argyridou, Stavroula
    Jaicim, Nishal B.
    Squire, Gareth
    Walters, Yvette
    Marsh, Anna-Marie
    McAdam, John
    Parke, Kelly S.
    Biglands, John D.
    Yates, Thomas
    Khunti, Kamlesh
    Davies, Melanie J.
    McCann, Gerry P.
    DIABETES CARE, 2020, 43 (06) : 1300 - 1310
  • [28] AN OPEN-LABEL 6-MONTH TRIAL OF THE EFFICACY OF ALLOPURINOL DOSE TITRATION IN PATIENTS WITH GOUT AS PART OF A ''TREAT TO TARGET'' STRATEGY
    Eliseev, S.
    Zhelyabina, V.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S330 - S330
  • [29] BLINDED VERSES OPEN-LABEL HYPNOTIC TAPERING FOR HYPNOTIC DISCONTINUATION: A RANDOMIZED CLINICAL TRIAL
    Edinger, Jack
    Wamboldt, Fredrick
    Eldridge-Smith, E. Devon
    Holm, Kristen
    Johnson, Rachel
    Simmons, Bryan
    Wang, Eileen
    Scherger, Rubab
    SLEEP, 2023, 46 : A147 - A147
  • [30] Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial
    van der Ende, Nadinda A. M.
    Roozenbeek, Bob
    Berkhemer, Olvert A.
    Koudstaal, Peter J.
    Boiten, Jelis
    van Dijk, Ewoud J.
    Roos, Yvo B. W. E. M.
    van Oostenbrugge, Robert J.
    Majoie, Charles B. L. M.
    van Zwam, Wim
    Lingsma, Hester F.
    van der Lugt, Aad
    Dippel, Diederik W. J.
    STROKE, 2022, 53 (01) : 61 - 69